Literature DB >> 10478161

Going the distance: the influence of practice location on the Ontario Maternal Serum Screening Program.

J A Permaul-Woods1, J C Carroll, A J Reid, C A Woodward, G Ryan, S Domb, S Arbitman, B Fallis, J Kilthei.   

Abstract

BACKGROUND: The Ontario Maternal Serum Screening (MSS) Program was introduced by the Ontario Ministry of Health as a province-wide pilot project in 1993. The objective of this study was to determine the influence of practice location on Ontario health care providers' use of and opinions regarding MSS, access to follow-up services and recommendations about the program.
METHODS: A questionnaire was mailed to a random sample of 2000 family physicians, all 565 obstetricians and all 62 registered midwives in Ontario between November 1994 and March 1995.
RESULTS: Among providers who were eligible (those providing antenatal care or attending births) the response rates were 91.4% (778/851), 76.0% (273/359) and 78.0% (46/59) respectively. Fewer respondents in the Northwest region (71.4%) and in rural areas (81.9%) stated that they routinely offer MSS to all pregnant women in their practices compared with respondents in other regions (84.4%-91.5%) and urban centres (90.1%). Fewer respondents in the northern regions (Northeast 49.2%, Northwest 25.0%) than in the Central East region (includes Toronto) (76.6%) felt that follow-up services were readily available. Respondents in the northern regions had less favourable opinions of MSS than those in the other regions in terms of its complexity, cost, the time involved in counselling and the high false-positive rate. More respondents in the Central East region (64.6%) and in urban centres (52.9%) recommended not changing the MSS program than did those in the Northwest (7.1%) and rural areas (39.8%). After provider characteristics were controlled for in a logistic regression analysis, practice location was not the most important factor. Instead, the model showed that respondents who cared for 50 or more pregnant women in the previous year were more likely to offer MSS routinely (OR 2.00, 95% CI 1.21-3.27) and that those who felt that patient characteristics affect the offering of MSS (OR 0.42, 95% CI 0.26-0.67) or that follow-up services were not readily available (OR 0.33, 95% CI 0.20-0.55) were less likely to offer it.
INTERPRETATION: Health care providers in northern and rural Ontario were less likely to offer MSS routinely than those in other regions and were more likely to recommend changing or eliminating the program. Providers' concerns about the social and cultural sensitivity of MSS and the availability of follow-up services affected use.

Entities:  

Mesh:

Year:  1999        PMID: 10478161      PMCID: PMC1230538     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  16 in total

1.  Prenatal screening for Down's syndrome with use of maternal serum markers.

Authors:  J E Haddow; G E Palomaki; G J Knight; J Williams; A Pulkkinen; J A Canick; D N Saller; G B Bowers
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.

Authors:  E Y Cheng; D A Luthy; A M Zebelman; M A Williams; R E Lieppman; D E Hickok
Journal:  Obstet Gynecol       Date:  1993-01       Impact factor: 7.661

3.  Correlates of certification in family medicine in the billing patterns of Ontario general practitioners.

Authors:  C A Woodward; M Cohen; B M Ferrier; C H Goldsmith; D Keane
Journal:  CMAJ       Date:  1989-11-01       Impact factor: 8.262

4.  Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.

Authors:  N J Wald; H Cuckle; J H Brock; R Peto; P E Polani; F P Woodford
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

5.  Informed consent to serum screening for Down syndrome: are women given adequate information?

Authors:  J Gekas; J Gondry; S Mazur; P Cesbron; F Thepot
Journal:  Prenat Diagn       Date:  1999-01       Impact factor: 3.050

6.  Effects of residency training in family medicine v. internship training on professional attitudes and practice patterns.

Authors:  B Maheux; C Beaudoin; A Jacques; J Lambert; A Lévesque
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

7.  Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

Authors:  N J Wald; A Kennard; J W Densem; H S Cuckle; T Chard; L Butler
Journal:  BMJ       Date:  1992-08-15

8.  Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.

Authors:  G E Palomaki; G J Knight; J E Haddow; J A Canick; D N Saller; D S Panizza
Journal:  Prenat Diagn       Date:  1992-11       Impact factor: 3.050

9.  Presenting a routine screening test in antenatal care: practice observed.

Authors:  T M Marteau; J Slack; J Kidd; R W Shaw
Journal:  Public Health       Date:  1992-03       Impact factor: 2.427

10.  Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.

Authors:  S F Goodburn; J R Yates; P R Raggatt; C Carr; M E Ferguson-Smith; A J Kershaw; P J Milton; M A Ferguson-Smith
Journal:  Prenat Diagn       Date:  1994-05       Impact factor: 3.050

View more
  6 in total

1.  What do they contribute? Family medicine residents who practise in cities.

Authors:  Joanna Bates; Rodney Andrew
Journal:  Can Fam Physician       Date:  2003-03       Impact factor: 3.275

2.  Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study.

Authors:  Robin Z Hayeems; Michael Campitelli; Xiaomu Ma; Tianhua Huang; Mark Walker; Astrid Guttmann
Journal:  CMAJ Open       Date:  2015-04-02

3.  Maternal serum screening in Newfoundland and Labrador: do attitude and knowledge affect physicians' practice?

Authors:  Jonathan Cavanagh; Maria Mathews
Journal:  Can Fam Physician       Date:  2006-10       Impact factor: 3.275

4.  Extracellular fluid management and hypertension in urban dwelling versus rural dwelling hemodialysis patients.

Authors:  Marcello Tonelli; Anita Lloyd; Neesh Pannu; Scott Klarenbach; Pietro Ravani; Kailash Jindal; Jennifer MacRae; Larry Unsworth; Braden Manns; Brenda Hemmelgarn
Journal:  J Nephrol       Date:  2016-08-23       Impact factor: 3.902

5.  Exploring informed choice in the context of prenatal testing: findings from a qualitative study.

Authors:  Beth K Potter; Natasha O'Reilly; Holly Etchegary; Heather Howley; Ian D Graham; Mark Walker; Doug Coyle; Yelena Chorny; Mario Cappelli; Isabelle Boland; Brenda J Wilson
Journal:  Health Expect       Date:  2008-09-16       Impact factor: 3.377

6.  Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study.

Authors:  Alison L Park; Tianhua Huang; Wendy S Meschino; Javaid Iqbal; Joel G Ray
Journal:  JNCI Cancer Spectr       Date:  2019-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.